Connect with us
Servier and Harvard researchers will embark on a three-year preclinical research project where the ultimate objective is to develop therapeutics targeting the microbiota for the treatment...
Merck and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Bavencio...
Researchers at Kanazawa University report in Nature Communications that a crystal of molecules known as pillar[5]arenes can form a host–guest compound with poly(ethylene oxides) polymers. The...
Researchers in the School of Pharmacy at the University of Nottingham have been using Dolomite Microfluidic’s chips to enhance their work on drug encapsulation and therapeutic...
Merck, a science and technology company, announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The...
The age-related macular degeneration (AMD) market has been dominated by big pharma companies and their pipeline candidates are ensuring a share of this lucrative market, in...
Merck and AstraZeneca’s Lynparza has been approved by the FDA for first-line maintenance therapy of BRCA-mutated ovarian cancer. “Lynparza is now the first PARP inhibitor to...
Immuno-oncology (I-O) drug development will remain at the forefront of the pharmaceutical industry in 2019, says GlobalData, a data and analytics company. The company’s latest annual...
Although development of interventions for emerging infectious diseases (EIDs) has traditionally been limited by a lack of market incentives, novel funding mechanisms and global partnerships for...
WuXi AppTec, a pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California....
